Curated News: National Heart, Lung, and Blood Institute (NHLBI)

Filters close
Newswise: NIH Statement on World Asthma Day 2020
4-May-2020 5:10 PM EDT
NIH Statement on World Asthma Day 2020
National Institute of Environmental Health Sciences (NIEHS)

Today on World Asthma Day, the National Institutes of Health stands with patients, families, advocates, researchers, and health care professionals to raise awareness about this common chronic respiratory disease, the people it affects, and the research that improves its prevention and treatment.

Newswise: Trial of Highly Touted Drug Begins at Montefiore and Einstein
Released: 29-Apr-2020 12:30 PM EDT
Trial of Highly Touted Drug Begins at Montefiore and Einstein
Albert Einstein College of Medicine

Researchers at Montefiore Health System and Albert Einstein College of Medicine have begun testing the drug hydroxychloroquine for the treatment of COVID-19, as part of a nationwide trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI).

Newswise: New University of Kentucky study could change what we know about platelets
Released: 29-Apr-2020 9:00 AM EDT
New University of Kentucky study could change what we know about platelets
University of Kentucky

The $6.6 million study will focus on how platelets function when they form clots in blood vessels and when they sense circulating pathogens, like viruses.

17-Apr-2020 4:55 PM EDT
Pulse Oximetry Monitoring Overused in Infants with Bronchiolitis
Children's Hospital of Philadelphia

Monitoring blood oxygen levels with continuous pulse oximetry is being overused in infants with bronchiolitis who do not require supplemental oxygen, according to a study by researchers at Children’s Hospital of Philadelphia (CHOP). The researchers found the use of continuous pulse oximetry occurred frequently and varied widely among hospitals in their sample, despite national recommendations advising against the practice.

Newswise: Reaching toward a cure for sickle cell disease
Released: 2-Apr-2020 3:35 PM EDT
Reaching toward a cure for sickle cell disease
Case Western Reserve University

The National Heart, Lung, and Blood Institute (NHLBI) has awarded Case Western Reserve University up to $3.7 million to assess emerging genome-editing based therapies being tested for curing sickle cell disease (SCD) at leading U.S research universities and hospitals. SCD is the most well-known among a group of inherited blood disorders, affecting about 100,000 people in the United States and about 20 million worldwide, according to a 2018 National Institutes of Health (NIH) statement announcing the NHLBI Cure Sickle Cell Initiative.

19-Mar-2020 1:00 PM EDT
National study finds diets remain poor for most American children; disparities persist
Tufts University

A study of national dietary trends over 18 years finds some improvements in the diets of U.S. children, but the majority still have a poor-quality diet. Disparities persisted or even worsened, finds the study published in JAMA and led by researchers at Tufts.

Newswise: Noncitizens are undertreated for heart attack, stroke risk factors
Released: 10-Mar-2020 10:35 AM EDT
Noncitizens are undertreated for heart attack, stroke risk factors
University of Illinois at Chicago

A new study shows that noncitizens in the United States are less likely to receive treatment for cardiovascular disease risk factors when compared with born or naturalized U.S. citizens.

Newswise: Clotting Problem
Released: 9-Mar-2020 11:15 AM EDT
Clotting Problem
University of Delaware

New research into why some people’s blood doesn’t clot well identified defects in the platelet-making process, where mutant cells aren’t behaving properly. Because these cells have a variety of different direction and movement issues, patients will need personalized drug therapies and treatments to treat patient-specific mutations.

4-Mar-2020 4:40 PM EST
Researchers Discover a New Diet-Associated Gut-Microbe Metabolite Linked to Cardiovascular Disease
Cleveland Clinic

Cleveland Clinic researchers have identified a gut microbe generated byproduct – phenylacetylglutamine (PAG) – that is linked to development of cardiovascular disease, including heart attack, stroke and death. The study was published in Cell today.

Released: 4-Mar-2020 1:55 PM EST
Wayne State University team receives $1.98 million NIH award to develop diagnostic tests for sarcoidosis
Wayne State University Division of Research

With the help of a $1.98 million award from the NIH, Wayne State University researchers are working to develop biomarker technology for identification of biomarkers of sarcoidosis, an inflammatory disease of unknown causes that affects multiple organs in the body.


Showing results

110 of 10

close
1.47864